|
| |
| | | 38133 | | 06.07.1977 | | Opella Healthcare Switzerland AG | | 21.12.2007 | | | | | | | | | | | 01.01.10. | | | | 01.01.10. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Aspégic 100 | Pulver in Beutel | Pulver (DL-Lysin Acetylsalicylat 180 mg) | N02BA01 | PI | | 02 | Aspégic Mite | Pulver in Beutel | Pulver (DL-Lysin Acetylsalicylat 450 mg) | N02BA01 | PI | | 03 | Aspégic 500 | Pulver in Beutel | Pulver (DL-Lysin Acetylsalicylat 900 mg) | N02BA01 | PI | | 04 | Aspégic Forte | Pulver in Beutel | Pulver (DL-Lysin Acetylsalicylat 1.8 g) | N02BA01 | PI |
|
|
|
